Senior Financial Planning Analyst (m/f/d)
Merck & Co.
This listing was originally posted on Merck & Co.'s careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moJob Description
We are continually striving to improve the understanding of health care within the local community. Our site in 1100 Vienna (ICON Tower) is a strategic location for the distribution of our high quality and innovative health care products, as well as digitally integrated solutions for our patients and clients. To ensure sustainable company growth, we continually aim to offer attractive career opportunities for more than 150 employees at our Vienna site.
Senior Financial Planning Analyst (m/f/d)
Role Overview
The Senior Financial Planning Analyst plays a key role in FP&A for our Human Health business in Austria, translating financial and business performance into actionable insights that support commercial decision-making. Working closely with business units, brand teams and Finance colleagues locally and regionally, the role takes ownership of defined areas of forecasting and performance analysis while acting as a trusted finance partner to the business.
Main Responsibilities
Requirements
We offer an attractive salary, outstanding social benefits and an exciting work environment with varied tasks in an international environment. The minimum annual salary for this position is EUR 61.300,- and varies according to the qualifications and experience of the successful candidate. We are looking forward to receiving your application.
We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another’s thinking and approach problems collectively. We are an equal opportunity employer, committed to fostering an inclusive and diverse workplace.
Additional location(s) Compensation Information:
Required Skills:
Adaptability, Business Partnerships, Business Planning, Data Visualization, Detail-Oriented, Economic Research, Finance Strategy, Financial Analysis, Financial Forecasting, Financial Modeling, Investments Analysis, Planning Budgeting And Forecasting (PBF), Preparation of Financial Reports, Profit and Loss (P&L) AnalysisPreferred Skills:
Current Employees apply HERE
Current Contingent Workers apply HERE
Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.
Employee Status:
RegularRelocation:
No relocationVISA Sponsorship:
NoTravel Requirements:
No Travel RequiredFlexible Work Arrangements:
HybridShift:
Not IndicatedValid Driving License:
NoHazardous Material(s):
N/AJob Posting End Date:
11/8/2026*A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Merck & Co.?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo